皮质类固醇反应的性别差异和IgA脏病的结果
Dana Kim1,2, Mark Woodward1,3, Jicheng Lv4
1The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.
Kidney international reports
|October 27, 2025
概括
皮质类固醇治疗有益于IgA脏病 (IgAN) 患者,不论性别. 然而,有Igan的男性面临的结局比女性更糟糕,这表明需要在Igan管理中考虑性别特异性.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
- 临床试验 临床试验
背景情况:
- 性别对IgA脏病 (IgAN) 治疗反应和结果的影响尚不清楚.
- 在全球范围内,Igan是原发性淋巴结膜炎的主要原因.
研究的目的:
- 为了评估性别对IGAN患者皮质类固醇反应的影响.
- 为了确定IGAN中性别和结局之间的关联.
主要方法:
- 在Igan全球 (测试) 试验数据中分析类固醇的治疗效果.
- 在6-9个月的时间内,Igan患者随机分配给甲基前尼索隆或安慰剂.
- 主要结局:由40%的eGFR下降,功能衰竭或死亡组成;次要结局包括蛋白尿和eGFR斜率.
主要成果:
- 甲基普雷尼索隆在没有显著的性别相互作用的情况下,在男性和女性中降低了主要结局风险 (P=0.47).
- 随着治疗,蛋白尿减少 (P=0.28) 或eGFR下降 (P=0.81) 没有观察到性别差异.
- 与女性相比,男性的初级结局风险更高 (HR=1.44,P=0.03) 和eGFR下降速度更快 (3.13毫升/分钟/1.73米2/年,P=0.006).
结论:
- 甲基普雷迪尼索隆改善Igan患者的结局,不论性别.
- 与女性相比,具有Igan的男性经历了较差的结局和更快的疾病进展.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
425
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
425
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.5K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.5K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
480
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
480
Inflammatory Bowel Disease IV: Pharmacological Management
471
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
471
Nephrotic Syndrome II : Assessment and Medical Management
192
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
192
Nephrotic Syndrome III : Nursing Management
277
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
277


